Related references
Note: Only part of the references are listed.HIV-associated multicentric Castleman's disease
Justin Stebbing et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial
Corey Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
More on HIV-Associated Kaposi's Sarcoma
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Brief communication: Rituximab in HIV-associated multicentric Castleman disease
Mark Bower et al.
ANNALS OF INTERNAL MEDICINE (2007)
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease
Tom Powles et al.
BLOOD (2007)
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-associated multicentric Castleman's disease:: ANRS 117 CastlemaB trial
Laurence Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Sang-Hoon Sin et al.
BLOOD (2007)
Management of AIDS-related Kaposi's sarcoma
Giuseppe Di Lorenzo et al.
LANCET ONCOLOGY (2007)
Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men
Corey Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma
Amelie Guihot et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Transmission of human herpesvirus 8 by blood transfusion
Wolfgang Hladik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study
C Casper et al.
SEXUALLY TRANSMITTED INFECTIONS (2006)
Signal transduction targets in Kaposi's sarcoma
Ryan Sullivan et al.
CURRENT OPINION IN ONCOLOGY (2006)
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
N Nishimoto et al.
BLOOD (2005)
Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells
E Caselli et al.
BLOOD (2005)
Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8
WJ Grossman et al.
BLOOD (2005)
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma
M Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care
C Casper
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
A Sodhi et al.
FASEB JOURNAL (2004)
Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment
C Casper et al.
BLOOD (2004)
HIV infection and human herpesvirus-8 oral shedding among men who have sex with men
C Casper et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An et al.
LEUKEMIA (2004)
Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women
MM Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity
Y Aoki et al.
BLOOD (2004)
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma
A Chadburn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-κB activation
QM Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
KSHV vFLIP binds to IKK-γ to activate IKK
N Field et al.
JOURNAL OF CELL SCIENCE (2003)
Human herpesvirus 8 epidemiology: What we do and do not know
NHTM Dukers et al.
AIDS (2003)
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors
P Barozzi et al.
NATURE MEDICINE (2003)
A pilot study of cidofovir in patients with Kaposi sarcoma
RF Little et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study
C Simonelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: The impact of highly active antiretroviral therapy
L Aaron et al.
CLINICAL INFECTIOUS DISEASES (2002)
Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men
C Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy
J Wilkinson et al.
JOURNAL OF VIROLOGY (2002)
Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells
TS Hyun et al.
JOURNAL OF VIROLOGY (2001)
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.
MJ Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells
SA Radkov et al.
NATURE MEDICINE (2000)
Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population
S Plancoulaine et al.
LANCET (2000)
Iatrogenic Kaposi's sarcoma - HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy
S Nagy et al.
TRANSPLANTATION (2000)
Share Paper
